Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Office Actions › UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS › 18686238
Last updated: April 22, 2026
Application No. 18/686,238

Untitled Application

Unknown
Filed
1600
Priority
Aug 26, 2021 — GB 2112240.3 +1 more
Examiner
RAMOS LEWIS, JOSMALEN MILAGROS
Art Unit
1621
Tech Center
UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS
Assignee
UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS
OA Round
1 (Non-Final)
53%
Grant Probability
Moderate
1-2
OA Rounds
2y 9m
Filing → Grant
78%
With Interview

This examiner grants 53% of cases after interview

— +25.6% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.
Based on 57 resolved cases, 2023–2026

Examiner Intelligence

RAMOS LEWIS, JOSMALEN MILAGROS View full profile →
Grants 53% of resolved cases
53%
Career Allowance Rate
30 granted / 57 resolved
-7.4% vs TC avg
Strong +26% interview lift
Without
With
+25.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
30 currently pending
Career history
87
Total Applications
across all art units

Statute-Specific Performance

§103
52.1%
+12.1% vs TC avg
§102
24.2%
-15.8% vs TC avg
§112
14.8%
-25.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 57 resolved cases

Prosecution Timeline

1600
Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

19/224,188
Patent 12595244
SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION
10m to grant Granted Apr 07, 2026
18/164,277
Patent 12565485
Solid forms of 1-((S)-4-((R)-7-(6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl)-6-chloro-8-fluoro-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)quinazolin-4-yl)-3-methylpiperazin-1-yl)prop-2-en-1-one
3y 0m to grant Granted Mar 03, 2026
18/907,296
Patent 12564572
TOPICAL OCULAR DELIVERY OF CROMAKALIM
1y 5m to grant Granted Mar 03, 2026
18/907,300
Patent 12564573
TOPICAL OCULAR DELIVERY OF CROMAKALIM
1y 5m to grant Granted Mar 03, 2026
18/971,536
Patent 12497371
NOVEL DRP-1 INHIBITORS AS THERAPEUTIC AGENTS
1y 0m to grant Granted Dec 16, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
53%
Grant Probability
78%
With Interview (+25.6%)
2y 9m
Median Time to Grant
Low
PTA Risk
Based on 57 resolved cases by this examiner. Grant probability derived from career allowance rate.

Ready to respond to this office action?

IP Author drafts your complete OA response — amendments, arguments, and claim strategy — in minutes, not days.

Start Drafting Your Response →

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month